PALB2 and triple-negative breast carcinoma: In the triple-negative breast cancer subgroup, the BRCA1/2 double mutation frequency was 0.06% (1/1773), and the BRCA1/2 and PALB2 triple mutation frequency was 0.06% (1/1773).